Fifth edition of MCADDI 2026 to be held at University of Hyderabad from October 25

Fifth edition of MCADDI 2026 to be held at University of Hyderabad from October 25 HYDERABAD The Federation of Asian Biotech Associations (FABA) will inaugurate the fifth edition of MCADDI 2026 (Medicinal Chemistry, Drug Discovery & Development India), a globally recognised programme presenting the full spectrum of drug discovery and development, at the University of Hyderabad on October 25. The six-day programme, being held in Hyderabad for the first time, will continue until October 30 and feature over 200 industry professionals and researchers. The programme will feature lectures by scientists from leading global pharmaceutical companies, including Pfizer, Bristol Myers Squibb, AbbVie and Novartis, and Indian organisations such as Aragen, Aurigene and Sai Life Sciences. According to FABA executive president Pallu Reddanna, India’s rapidly growing drug discovery ecosystem has increased the demand for well-trained medicinal chemists and drug discovery scientists.